FASN inhibition as a potential treatment for endocrine-resistant breast cancer.
Gruslova A, McClellan B, Balinda HU, Viswanadhapalli S, Alers V, Sareddy GR, Huang T, Garcia M, deGraffenried L, Vadlamudi RK, Brenner AJ.
Gruslova A, et al. Among authors: brenner aj.
Breast Cancer Res Treat. 2021 Jun;187(2):375-386. doi: 10.1007/s10549-021-06231-6. Epub 2021 Apr 24.
Breast Cancer Res Treat. 2021.
PMID: 33893909